Beiersdorf 2025 Results: Eucerin and Aquaphor Drive Growth as Nivea Undergoes Strategic Recalibration

Table of Contents

1. Key Highlights:
2. Introduction
3. Financial performance at a glance: steady growth, improving profitability
4. Brand-by-brand performance: winners and laggards within the portfolio
5. Why dermo-cosmetics outperformed: efficacy, trust and channel dynamics
6. Luxury skincare’s volatility: why La Prairie weakened and how the segment behaves
7. Strategic recalibration for Nivea: focusing on face care and local market needs
8. Market headwinds and 2026 outlook: cautious consumer demand and retail disruptions
9. Operational levers and margin management: how Beiersdorf improved profitability
10. What competitors and analysts will watch: metrics that matter in 2026–2027
11. Tactical moves Beiersdorf can deploy to strengthen long-term positioning
12. Broader industry implications: what Beiersdorf’s results signal for the skincare sector
13. Real-world comparisons: how peers have navigated similar dynamics
14. Risks and uncertainties that could reshape 2026 outcomes
15. What success looks like for Beiersdorf in 2027
16. FAQ

Key Highlights:

• Beiersdorf reported organic sales growth of 2.4% in 2025 to EUR 9.9 billion, with EBIT excluding special factors rising to EUR 1.4 billion and an EBIT margin of 14.0%.
• Dermo-cosmetic brands Eucerin and Aquaphor surged with 11.7% organic growth to EUR 1.5 billion, while flagship mass-market brand Nivea grew 0.9% and luxury label La Prairie declined 4.5%.
• Management is recalibrating Nivea’s strategy—shifting emphasis to face care and local market adaptation in priority markets—while projecting a cautiously flat Consumer Business Segment for 2026 amid retail disruptions and volatile consumer demand.

Introduction

Beiersdorf closed 2025 with a set of results that combine resilience, targeted outperformance and clear strategic stress points. The group’s topline climbed to EUR 9.9 billion on an organic increase of 2.4%, and operating profit before special items reached EUR 1.4 billion—an incremental step in restoring pre-crisis margin levels. Underneath the headline numbers, however, the company’s portfolio tells a mixed story. Its dermo-cosmetic franchises recorded strong momentum. The mass-market heavyweight Nivea showed only modest gains and is being repositioned. La Prairie, the group’s bridge into luxury, weakened as high-end segments wrestled with travel retail volatility and cautious discretionary spending.

These results matter beyond one balance sheet. They reflect structural shifts across global skincare: consumers allocating more to clinically backed dermo brands, premium labels feeling the protracted aftershocks of travel retail and tourism patterns, and mass-market players needing faster local adaptation and sharper innovation cycles. Beiersdorf’s response—tightening cost controls, concentrating innovation where consumer demand is strongest, and recalibrating Nivea—provides a case study in portfolio management amid mixed market dynamics.

The sections that follow break down the 2025 results, examine why dermo brands outperformed while luxury lagged, unpack the strategic adjustments underway for Nivea, and lay out what investors, retail partners and competitors should watch through 2026 and 2027.

Financial performance at a glance: steady growth, improving profitability

Beiersdorf ended 2025 with nominal net sales of EUR 9.9 billion, reflecting 2.4% organic growth. That pace placed the company ahead of many peers in the global skincare arena, where growth slowed across regions. Profitability trends moved in a favorable direction: EBIT excluding special factors rose to EUR 1.4 billion and the related margin ticked up to 14.0% from 13.9% the year before. These numbers point to two simultaneous forces: revenue resilience driven by targeted brand growth and margin recovery supported by disciplined cost management.

The Consumer Business Segment, which houses core brands such as Nivea, Eucerin, Labello and others, achieved organic growth of 2.5% and posted nominal sales of EUR 8.2 billion. Geographically, growth was broad-based—Europe contributed 0.9% organic growth, the Americas 3.1% and Africa/Asia/Australia 4.5%—indicating the group’s ability to unlock pockets of demand despite uneven regional conditions.

Several operational levers underpinned margin expansion. Beiersdorf cited ongoing cost discipline and improved operational efficiencies. Where companies in this sector have found gains—inventory optimization, SKU rationalization, tighter promotional spending, and a stronger shift to higher-margin channels like direct-to-consumer and owned e-commerce—Beiersdorf’s performance suggests it has captured some of these efficiencies without sacrificing innovation and marketing support for growth engines.

The overall picture is one of measured progress. The company clearly outperformed the broader global skincare market in 2025, but meaningful questions remain around brand mix and near-term revenue drivers.

Brand-by-brand performance: winners and laggards within the portfolio

Reading Beiersdorf’s results requires looking beneath group totals at how individual brands moved. The distribution of growth exposes where consumers are spending and where the company must adjust strategy.

Nivea: The flagship’s mixed performance Nivea, Beiersdorf’s most recognizable and largest brand, recorded organic sales growth of 0.9% in 2025, achieving nominal sales of EUR 5.5 billion. For a brand of Nivea’s scale, a single-digit pace is functionally flat when adjusted for regional and category rotations. The mass-market segment that Nivea predominantly serves remains highly competitive and price-sensitive. Consumers in many markets have tightened discretionary spend, and large-format retailers and omnichannel players have exerted greater pricing pressure.

That performance prompted Beiersdorf to start a recalibration of Nivea’s strategy in 2025. Management signaled a concentrated push into face care—a category with higher margins and stronger consumer interest in efficacy and dermatological credibility. The company also committed to breakthrough innovations and plans to adjust execution through 2026 and 2027 to better tailor offerings to local needs in top markets such as China, the United States, India, Japan and Brazil.

Eucerin and Aquaphor: The dermo-cosmetic uplift By contrast, Beiersdorf’s dermo-cosmetic brands—chiefly Eucerin and Aquaphor—delivered standout results, growing organically by 11.7% to reach nominal sales of EUR 1.5 billion. These brands benefited from several converging trends. Consumers increasingly prioritize products with clinically validated claims, particularly for sensitive, aging or compromised skin. Dermo brands occupy a space where science, medical endorsement and perceived effectiveness converge, enabling premium pricing and loyalty that mass-market products struggle to sustain.

Growth in dermo also reflects favorable channel dynamics. Pharmacy and specialist retail, as well as channels driven by recommendation—dermatologists, pharmacists, and online health portals—have supported conversion for brands that can demonstrate tangible outcomes. Eucerin and Aquaphor benefited from product extensions, selective geographic rollouts and likely higher conversion in markets where skin health and repair are central concerns.

La Prairie: luxury under pressure La Prairie, Beiersdorf’s luxury skincare arm, recorded a 4.5% decline in organic sales in 2025, finishing the year with nominal sales of EUR 478 million. The luxury skincare sector often feels the effects of travel retail swings and fluctuations in discretionary spending more acutely than mass-market segments. When tourists return in lower numbers or when wealthier consumers delay luxury purchases in uncertain economic climates, sales can drop sharply. Luxury buyers also shift rapidly to experiential spending or to niche, artisanal brands perceived as more exclusive, and that dynamic pressures established prestige labels to keep pace with innovation and storytelling.

Across the portfolio, the divergent trajectories underline a fundamental market segmentation: consumers are prepared to pay for demonstrable efficacy and targeted treatments while becoming more selective in mass and luxury purchases. That segmentation shapes Beiersdorf’s strategic priorities for product development and go-to-market investments.

Why dermo-cosmetics outperformed: efficacy, trust and channel dynamics

The outperformance of Eucerin and Aquaphor exposes a broader structural shift in consumer behavior. Several factors explain why dermo-cosmetic products have become a faster-growing segment than mass-market offerings.

Efficacy as the primary purchase driver Buyers now expect more than sensory appeal or pleasant fragrances. They want products that deliver measurable improvement—reduced redness, strengthened barrier function, diminished signs of aging. Clinical claims, backed by published studies or accepted dermatological endorsements, help brands justify premium pricing and reduce sensitivity to discounting. Eucerin’s long-standing position as a clinically respected brand and Aquaphor’s reputation for repair and barrier support gave them a competitive advantage.

Trust and professional recommendation Dermatologist and pharmacist recommendations matter. A GP or skin specialist endorsing a product drives trial and conversion in ways that social media hype sometimes cannot. Consumers with persistent skin conditions are more likely to seek out scientifically grounded brands. The dermo category also benefits from repeat purchase behavior; when a formulation delivers measurable relief, consumers become loyal over longer cycles.

Channels that favor dermo brands Pharmacy distribution and targeted e-commerce platforms emphasize product information, reviews and professional endorsements. These channels are less promotional and more education-driven, allowing dermo brands to preserve margin. Additionally, telehealth platforms and online skin-diagnostic tools have improved access to personalized recommendations, which further directs consumers to clinically oriented brands.

Demographics and aging populations Aging demographics in developed markets increase demand for efficacious treatments that address age-related skin issues. Consumers in middle and older age brackets typically spend more on skincare that promises visible results. This trend will likely continue to support dermo-cosmetics as global populations age and as middle-class cohorts expand in emerging markets.

Taken together, these forces create a robust environment for dermo brands. For companies that can couple credible science with strong distribution and clear marketing, dermo offers a growth path that is more insulated from price competition and episodic brand fads.

Luxury skincare’s volatility: why La Prairie weakened and how the segment behaves

Luxury skincare sits at an intersection of prestige branding, retail footprint and consumer confidence. La Prairie’s 4.5% decline in organic sales highlights vulnerabilities common to prestige players.

Travel retail dependence and tourism patterns Luxury skincare often gains a disproportionate share of its sales through travel retail—duty-free shops at airports and destinations that capture purchases from cross-border shoppers and tourists. If tourism patterns shift, travel retail suffers immediately. The source points to China travel retail disruptions as part of Beiersdorf’s concerns for early 2026; similar disruptions can quickly undercut luxury sales, particularly in markets where tourists account for a significant share of purchases.

Shifts in consumer preferences within luxury High-net-worth consumers increasingly seek experiences—travel, dining, wellness—alongside or instead of traditional luxury goods. Within beauty, rapid proliferation of niche luxury brands that emphasize small-batch formulations, artisanal provenance or unique sensorial experiences challenge established prestige houses to refresh narratives continually. A storied brand must balance heritage with the freshness that modern affluent consumers demand.

Sensitive to macroeconomic swings Luxury purchases are uneven during periods of economic uncertainty. Heavy discounting to preserve volume erodes brand equity, but avoiding discounts can push consumers to delay purchases. Luxury brands must calibrate regional offers and channel mixes to maintain exclusivity while preserving revenue.

La Prairie’s decline is not necessarily permanent; well-executed innovation, strengthened travel retail partnerships, and refreshed storytelling can revive momentum. The brand’s path forward will hinge on restoring relevance with high-spending consumers while navigating an uncertain travel retail landscape.

Strategic recalibration for Nivea: focusing on face care and local market needs

Beiersdorf initiated a recalibration of Nivea in 2025. For a brand with Nivea’s scale, the move acknowledges that incremental tweaks are insufficient. The recalibration centers on face care and breakthrough innovations and will be refined through 2026 and 2027 to align with local consumer preferences in crucial markets.

Why prioritize face care? Face care offers higher price points and stronger consumer willingness to pay for functional benefits, particularly when products include active ingredients that address hydration, protection, pigmentation and early signs of aging. Face care also provides opportunities for premiumization within an otherwise mass-market brand framework. By concentrating R&D and marketing investments on face care, Nivea stands to capture greater margin and maintain relevance among consumers who increasingly equate facial regimens with skin health.

Local adaptation in priority markets Beiersdorf identified China, the United States, India, Japan and Brazil as priority markets for localized strategy implementation. Local adaptation can mean tailoring formulations for climate (e.g., humidity, UV exposure), skin tone and consumer habits, as well as customizing packaging sizes and price points. Regulatory nuances in these markets also guide product claims and ingredient use, creating further need for market-specific launches.

Innovation and marketing repositioning A breakthrough innovation can re-anchor a brand, but it must be differentiated and clearly communicated. For Nivea, innovation at the ingredient or delivery-system level—such as rapid-absorb technologies, hybrid skincare-makeup formulations, or clinically validated actives—could catalyze renewed interest. Marketing must emphasize tangible benefits and leverage trusted messengers—dermatologists, consumer testimonials and clinical data—so that consumers see Nivea as both accessible and effective.

Channel strategy: balancing volume and margin Nivea’s mass-market roots mean it must balance traditional large-format retail partners with growing e-commerce and direct-to-consumer channels. Digital-first launches or exclusive DTC collections can test higher-margin concepts before scaling them into mass channels. Collaborations with retailers on localized assortments and promotional calendars will be critical in markets with strong brick-and-mortar ecosystems.

Measured expectations for the recalibration Recalibrating a global household brand is a multi-year endeavor. Short-term fluctuations are likely as the company experiments with formats and channel mixes. Success will be measured by the brand’s ability to accelerate growth in face care categories, improve price realization, and maintain strong distribution while reducing vulnerability to discount-driven competition.

Market headwinds and 2026 outlook: cautious consumer demand and retail disruptions

Beiersdorf expects the Consumer Business Segment’s net sales in 2026 to be flat to slightly growing, citing continued market volatility and cautious consumer demand. The group highlighted specific headwinds: disruptions in the US retail landscape and ongoing challenges in China travel retail. The first quarter of 2026 is expected to be weaker than the full-year range, partly due to a lower innovation impact for Nivea compared to Q4 2025.

Understanding the cited retail disruptions

• US retail landscape: The United States has seen restructuring across retail categories—store portfolio optimizations, inventory normalization after pandemic-driven overstocking, and higher expectations for profitability per square foot. Such shifts can result in temporary de-stocking and reduced promotional activity during transition periods. For FMCG and cosmetics, this environment can compress sell-in for brands that depend on promotional calendars and heavy retail visibility.
• China travel retail: Travel retail in China is a bellwether for premium and luxury brands. Travel retail created a growth channel for duty-free and cross-border purchases, but its performance depends on inbound and outbound tourism flows, consumer sentiment and regulatory noise around cross-border shopping. Any disruption—be it regulatory, tourism recovery delays, or operational setbacks—can disproportionately affect prestige brands and delta volumes for luxury-focused products.

Cautious consumers and promotional dynamics Across multiple markets, consumers are more deliberate with discretionary spending. When households prioritize essentials, categories like mass-market personal care face trade-offs between penetration and price. Brands that rely on promotional amplification risk margin erosion. Consequently, preservation of margin while retaining consumer relevance will be a central challenge for Beiersdorf in 2026.

Innovation cadence and timing Beiersdorf’s comment that Q1 2026 will be affected by a lower innovation impact from Nivea underscores the role product launches play in short-term revenue shifts. Timing innovations to match promotional windows and travel seasons remains critical. The company will need to coordinate its innovation cadence and launch geographies strategically to mitigate quarter-on-quarter volatility.

Implications for the organization Flat to slightly growing expectations are realistic in a market where growth pockets are uneven. Success will depend not only on product performance but also on execution—managing inventories with retail partners, optimizing channel mixes, and accelerating targeted marketing in markets where consumer appetite is stronger.

Operational levers and margin management: how Beiersdorf improved profitability

EBIT excluding special factors rose to EUR 1.4 billion in 2025 and margins edged up to 14.0%. That improvement came without a dramatic top-line acceleration, indicating the company extracted operating efficiencies.

Key operational levers likely at play

• Cost discipline: Controlling fixed and variable costs, rationalizing non-performing SKUs and tightening discretionary spend on less effective campaigns can materially improve profitability. These measures preserve profitability while allowing reinvestment in growth categories.
• Supply chain optimization: Improved forecasting, supplier renegotiations and logistics efficiencies can reduce cost of goods sold and working capital needs. Many consumer groups have restructured procurement and manufacturing footprints to respond more quickly to demand swings.
• Channel mix optimization: Favoring higher-margin channels such as e-commerce, selective wholesale and direct-to-consumer offerings improves overall margin. Reducing reliance on price-promotional retail channels can further protect profitability.
• Marketing efficiency: Greater use of data to target high-potential customer segments and better measurement of return on ad spend (ROAS) enables smarter allocation of marketing budgets. Brands that can attribute spend to conversion with higher fidelity can scale effective campaigns while cutting waste.

Sustaining margin gains Sustained margin recovery requires balancing efficiency with investment. Short-term cost cuts that undermine brand equity or product quality can hurt long-term growth. Beiersdorf’s challenge is to maintain the recovery trajectory while funding the Nivea recalibration and supporting high-growth dermo brands.

What competitors and analysts will watch: metrics that matter in 2026–2027

Investors and competitors will focus on several measurable outcomes to assess whether Beiersdorf’s strategy is effective.

Nivea’s face care traction Market share moves within the face care category will be a leading indicator. Analysts will look for evidence of improved pricing, successful premium sub-lines and sales acceleration in target markets. Repeat purchase rates, unit value improvements and reduced promotional intensity will signal strategic progress.

Momentum of dermo brands Sustained double-digit growth from Eucerin and Aquaphor would confirm structural demand for dermo products. Geographic expansion success, new product pipelines and higher basket values in pharmacy channels will be watched closely.

Recovery or stabilization for La Prairie For luxury, signs of recovery in travel retail, improved sell-through at high-end counters and successful limited-edition or celebrity-collaborative launches would indicate stabilization. Revenue per square meter and sell-through rates in flagship stores and concessions will reveal consumer appetite.

Margin sustainability EBIT margin progression without reliance on one-off items will be critical. Investors will track gross margin, advertising-to-sales ratios and operating leverage. Any reversal in margin trajectory could raise questions about pricing power and cost efficiency.

Execution in priority markets Progress in China, the US, India, Japan and Brazil will be pivotal. Localized product introductions, targeted campaigns, and improved distribution in these markets are required for sustainable growth. Market-level performance will provide a barometer for Beiersdorf’s ability to execute complex, localized strategies.

Innovation pipeline and launch impact New product success metrics—conversion rates, early sell-through, and consumer sentiment—will indicate whether innovation investments translate into revenue. The timing of launches relative to seasonal demand and travel cycles will be an important consideration.

Tactical moves Beiersdorf can deploy to strengthen long-term positioning

A company with Beiersdorf’s heritage has a range of tools to respond to the market pressures and opportunities ahead. The following tactical moves present plausible, low-risk steps to accelerate growth and protect margin.

1. Double down on dermo: invest in clinical research and expand distribution

• Expand Eucerin and Aquaphor into adjacent treatment areas backed by clinical trials.
• Strengthen partnerships with dermatologists and pharmacy chains to enhance recommendation and shelf prominence.
• Use tele-dermatology platforms to connect product recommendations with treatment plans, creating a direct pathway from diagnosis to purchase.

2. Premiumize parts of Nivea selectively

• Introduce premium sub-lines under the Nivea umbrella focused on active ingredients and clean-label formulations.
• Launch limited DTC-exclusive face-care lines to test consumer response and willingness to pay before scaling to mass channels.
• Employ tiered packaging and ingredient transparency to justify higher price points.

3. Local-market innovation and rapid prototyping

• Establish market-specific product teams in China, India and Brazil to prototype formulations and adapt marketing quickly.
• Shorten the product development lifecycle through modular formulations and smaller batch testing to reduce time-to-market.

4. Rebalance channel mix toward profitable outlets

• Expand direct-to-consumer capabilities with compelling subscription and loyalty propositions for repeat-use dermo products.
• Strengthen e-commerce partnerships with localized marketplaces and healthcare platforms to capture higher-margin digital sales.

5. Reinvigorate La Prairie with storytelling and selective exclusivity

• Leverage limited-edition releases and personalized services (e.g., in-counter consultations) to restore desirability.
• Build partnerships with luxury travel and lifestyle brands to reconnect with high-spending consumers in experiential contexts.

6. Optimize promotional strategies

• Move away from blanket discounting toward targeted promotions and bundled offers that preserve unit economics.
• Deploy CRM-driven offers to high-value customers and use data analytics to optimize promotional cadence.

7. Invest in sustainability-linked product narratives where credible

• Consumers value environmental and social responsibility, but claims must be substantiated. For mature brands like Nivea and Eucerin, demonstrable improvements in packaging recyclability or ingredient sourcing can enhance brand equity without distracting from efficacy claims.

Implementation of these tactics requires disciplined investment and rapid learning cycles to understand what works across differing markets. The objective is not wholesale reinvention but precise adjustments that tilt the portfolio toward higher-growth, higher-margin segments.

Broader industry implications: what Beiersdorf’s results signal for the skincare sector

Beiersdorf’s 2025 performance offers lessons for competitors and newcomers alike.

• The clinical premium is expanding. Brands that can demonstrate efficacy via trials, real-world evidence and professional endorsement will command a larger share of consumer spend.
• Mass-market scale remains a valuable asset but requires nimble local execution. Legacy household brands will only hold share if they adapt product formulations, communication and channel strategy to local consumer needs and maintain innovation that resonates with current priorities such as face care.
• Luxury skincare’s recovery is uneven and linked to travel retail and high-income consumer sentiment. Prestige players must diversify channels and refresh narratives to maintain aspirational status.
• Margin recovery is achievable through operational discipline without sacrificing innovation. Companies that balance cost controls with targeted investments will outperform peers in a cautious market.
• The role of omnichannel is more strategic than tactical. E-commerce and DTC play critical roles in margin improvement, but retailers remain important for mass brands. The ability to orchestrate channels for different brands and categories is a competitive advantage.

These implications will drive strategic decisions across the sector: where to allocate R&D budgets, how to structure distribution, and which consumer segments to prioritize.

Real-world comparisons: how peers have navigated similar dynamics

Several major players in beauty and personal care illustrate paths that mirror the trends seen in Beiersdorf’s results.

• A large cosmetics conglomerate refocused on clinical and premium mass brands by launching dermatologist-backed ranges and strengthening pharmacy channels. It leveraged telehealth partnerships to capture recommendation-driven sales, showing that investing in professional endorsement can accelerate dermo category growth.
• A prestige beauty group diversified its retail exposure beyond airports after travel retail volatility dented luxury sales. By expanding experiential stores and exclusive online drops, it rebounded in markets where affluent consumers sought unique experiences rather than standard brand offerings.
• A mass-market leader revamped its hero brand with a science-led sub-line sold initially through DTC channels. The strategy preserved mass-market volume while enabling margin expansion and valuable consumer data capture.

These comparative cases suggest that the combination of science-backed products, channel diversification and local market customization is an effective framework for resilience.

Risks and uncertainties that could reshape 2026 outcomes

Forecasting 2026 involves several material risks that could push Beiersdorf’s performance away from current expectations.

• Macro shocks: sudden inflation spikes or currency swings in key markets could compress margins or weaken consumer purchasing power.
• Retail consolidation: further restructuring among global retailers could alter shelf economics, forcing rapid adjustments to distribution strategies or promotional commitments.
• Regulatory developments: changes around ingredient approvals, labeling standards or cross-border commerce could impact product claims and market access.
• Competitive disruption: agile indie brands or large competitors launching compelling dermo or premium-mass offerings could capture share rapidly, particularly in digitally native channels.
• Innovation missteps: expensive R&D investments that fail to convert into commercially compelling products would depress near-term margins and investor confidence.

Mitigating these risks requires scenario planning, flexible supply chains and an empirical, test-and-learn approach to launches and market entry.

What success looks like for Beiersdorf in 2027

Three measurable outcomes would indicate that Beiersdorf’s strategic course is yielding results by the end of 2027.

1. Accelerated face-care growth within Nivea If Nivea’s face care segment records sustained double-digit growth in key markets, the recalibration will have demonstrated traction.
2. Dermo brands consolidate share and expand margins Sustained high-single to double-digit growth from Eucerin and Aquaphor, combined with improved gross margin and higher basket values in pharmacy and digital channels, would validate the portfolio tilt toward clinically backed solutions.
3. Stabilization and selective rejuvenation of premium segments La Prairie showing signs of recovery via improved sell-through in travel retail and luxury counters, plus successful limited-edition launches or partnerships, would indicate the luxury strategy is stabilizing.

Delivering on these outcomes will require disciplined capital allocation, sharper go-to-market execution and continued operational efficiency to preserve margins while enabling growth.

FAQ

Q: What were Beiersdorf’s total sales and profit metrics for 2025? A: Beiersdorf reported nominal net sales of EUR 9.9 billion in 2025, with organic growth of 2.4%. EBIT excluding special factors increased to EUR 1.4 billion, and the EBIT margin excluding special factors rose slightly to 14.0% from 13.9% the prior year.

Q: Which brands drove growth and which struggled? A: Dermo-cosmetic brands Eucerin and Aquaphor led performance, delivering 11.7% organic growth to reach EUR 1.5 billion in sales. Nivea, the company’s main mass-market brand, grew organically by 0.9% to EUR 5.5 billion. La Prairie, the luxury segment, recorded a 4.5% organic decline to EUR 478 million.

Q: Why is Beiersdorf recalibrating Nivea? A: The recalibration targets stronger performance in face care, seeks breakthrough innovations and aims to tailor offerings to local consumer preferences in priority markets. The move responds to a challenging mass-market environment, where price sensitivity, competition and evolving consumer expectations necessitate a fresh strategy.

Q: How does travel retail affect Beiersdorf’s performance? A: Travel retail matters particularly for premium and luxury brands. Disruptions in China travel retail were cited as a factor hurting early 2026 performance expectations. Reduced tourism and airport shopping can significantly lower sell-through for prestige products.

Q: What is Beiersdorf’s outlook for 2026? A: The company expects Consumer Business Segment net sales to be flat to slightly growing in 2026, noting continued market volatility and cautious consumer demand. The first quarter of 2026 is expected to be below the full-year range due to US retail disruptions, challenges in China travel retail, and a lower innovation impact from Nivea compared to late 2025.

Q: Can Beiersdorf sustain its margin improvements? A: Margin improvement in 2025 was driven by operational efficiencies and cost discipline. Sustaining that trend will require balancing further efficiency gains with targeted investments in innovation, marketing and local market execution—particularly for Nivea’s recalibration and support for high-growth dermo brands.

Q: What should investors monitor in the next 12–24 months? A: Key indicators include Nivea’s face care revenue growth and price realization, continued double-digit growth from dermo brands, stabilization in La Prairie’s luxury performance, EBIT margin progression without one-off factors, and execution success in priority markets (China, US, India, Japan, Brazil).

Q: What tactical steps could improve Beiersdorf’s performance? A: Potential measures include expanding clinical research and pharmacy partnerships for dermo brands, premiumizing selected Nivea sub-lines via DTC launches, localizing product development in priority markets, optimizing channel mix toward higher-margin outlets, and refreshing luxury storytelling with limited exclusives and experiential initiatives.

Q: How do these results influence the broader skincare industry? A: The results underscore two broad trends: a growing consumer preference for clinically validated dermo products and increasing fragility in premium and mass-market segments that do not adapt quickly to local preferences and innovation demands. Companies that combine science, nimble local execution and selective channel optimization will be better positioned.

Q: Is Beiersdorf well placed to navigate the 2026 market environment? A: Beiersdorf appears well positioned in several respects: it has a strong dermo portfolio with momentum, a recognizable mass-market franchise undergoing recalibration, and evidence of improving operational discipline. Execution risk remains the primary variable—delivering localized innovation, protecting margins, and stabilizing premium offerings amid retail shifts will determine near-term success.